日本新薬【4516】 利益剰余金の推移

機能の使い方
(単位:百万円) 利益剰余金 前年比(%)
3Q26 242,446 +10.8%
2Q26 236,209 +12.2%
1Q26 228,538 +11.8%
4Q25 222,640 +12.3%
3Q25 218,803 +11.4%
2Q25 210,457 +9.2%
1Q25 204,348 +10.3%
4Q24 198,260 +9.9%
3Q24 196,457 +8.9%
2Q24 192,806 +9.2%
1Q24 185,344 +9.3%
4Q23 180,433 +9.2%
3Q23 180,406 +10.5%
2Q23 176,568 +10.0%
1Q23 169,579 +8.5%
4Q22 165,303 +12.2%
3Q22 163,196 +15.1%
2Q22 160,585 +16.3%
1Q22 156,366 +15.1%
4Q21 147,391 +10.9%
3Q21 141,775 +10.8%
2Q21 138,063 +8.5%
1Q21 135,844 +9.7%
4Q20 132,886 +9.2%
3Q20 127,905 +8.3%
2Q20 127,207 +12.2%
1Q20 123,866 +11.3%
4Q19 121,677 +11.6%
3Q19 118,072 +9.5%
2Q19 113,365 +8.1%
1Q19 111,291 +9.3%
4Q18 109,078 +9.2%
3Q18 107,786 +6.3%
2Q18 104,875 +11.8%
1Q18 101,835 +10.2%
4Q17 99,897 +11.4%
3Q17 101,423 +14.8%
2Q17 93,843 +9.4%
1Q17 92,440 +8.9%
4Q16 89,658 +5.3%
3Q16 88,335 -
2Q16 85,784 -
1Q16 84,871 -
4Q15 85,137 -